INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

Nautilus Biotechnology, Inc.

Filed

May 24, 2021

Period of Report

May 20, 2021

Accession Number

0001062993-21-005013